Receptors, Prostaglandin E, EP2 Subtype, agonists
- Name
- Receptors, Prostaglandin E, EP2 Subtype, agonists
- Accession Number
- DBCAT002836
- Description
Not Available
- Drugs
Drug Drug Description Taprenepag Taprenepag has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle. Omidenepag isopropyl An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. - Drugs & Drug Targets
Drug Target Type Omidenepag isopropyl Carboxylesterase enzyme Omidenepag isopropyl Prostaglandin E2 receptor EP2 subtype target Omidenepag isopropyl Prostaglandin E2 receptor EP1 subtype target